Actuate Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BIOS CAPITAL MANAGEMENT, LP | 11/12/2025 | 10.05 M | $67.23 M | 0.85% | 51.15% |
| VOSS CAPITAL, LLC | 11/20/2025 | 896.28 K | $6.00 M | 213.23% | 4.56% |
| VANGUARD GROUP INC | 11/07/2025 | 316.01 K | $2.11 M | 19.49% | 1.61% |
| BLACKROCK, INC. | 11/12/2025 | 282.07 K | $1.89 M | 44.32% | 1.44% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 145.41 K | $972.81 K | 23.18% | 0.74% |
| NORTHERN TRUST CORP | 11/14/2025 | 85.45 K | $571.69 K | -0.28% | 0.44% |
| STATE STREET CORP | 11/14/2025 | 49.90 K | $333.80 K | 58.83% | 0.25% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/14/2025 | 19.30 K | $129.12 K | 4.23% | 0.10% |
| GLEASON GROUP, INC. | 10/16/2025 | 19.03 K | $127.30 K | 0.00% | 0.10% |
| SFMG, LLC | 11/13/2025 | 17.00 K | $113.73 K | 16.84% | 0.09% |
| LPL FINANCIAL LLC | 11/12/2025 | 16.22 K | $108.48 K | -13.31% | 0.08% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 14.77 K | $98.78 K | 0.00% | 0.08% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 13.54 K | $90.60 K | 5.83% | 0.07% |
| ROYAL BANK OF CANADA | 11/14/2025 | 12.95 K | $86.00 K | 876.19% | 0.07% |
| FREESTONE CAPITAL HOLDINGS, LLC | 11/12/2025 | 10.00 K | $66.90 K | 0.00% | 0.05% |
| UBS GROUP AG | 11/13/2025 | 8.93 K | $59.72 K | 280.36% | 0.05% |
| BARCLAYS PLC | 11/12/2025 | 8.87 K | $59.31 K | -76.25% | 0.05% |
| RHUMBLINE ADVISERS | 11/06/2025 | 8.77 K | $58.65 K | -3.46% | 0.04% |
| MORGAN STANLEY | 11/14/2025 | 7.63 K | $51.02 K | -1.47% | 0.04% |
| NORTHWESTERN UNIVERSITY | 10/29/2025 | 6.49 K | $43.41 K | -76.64% | 0.03% |
| GLOBAL RETIREMENT PARTNERS, LLC | 10/21/2025 | 6.25 K | $41.81 K | 0.00% | 0.03% |
| NEW YORK STATE COMMON RETIREMENT FUND | 11/03/2025 | 6.20 K | $41.48 K | -63.95% | 0.03% |
| WEALTHSPIRE ADVISORS, LLC | 11/14/2025 | 5.00 K | $33.45 K | 100.00% | 0.03% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 4.87 K | $32.59 K | -68.14% | 0.02% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2025 | 2.68 K | $17.95 K | -15.87% | 0.01% |
| JPMORGAN CHASE & CO | 11/26/2025 | 2.48 K | $16.62 K | -10.65% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.64 K | $10.99 K | 12,538.46% | 0.01% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 1.56 K | $10.44 K | 72.38% | 0.01% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 1.26 K | $8.42 K | -87.95% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 1.00 K | $8.44 K | 0.00% | 0.01% |
| PROSIGHT MANAGEMENT, LP | 11/14/2025 | 885 | $5.92 K | 100.00% | 0.00% |
| LEGAL & GENERAL GROUP PLC | 11/13/2025 | 708 | $4.74 K | 0.00% | 0.00% |
| AMERITAS INVESTMENT PARTNERS, INC. | 11/10/2025 | 601 | $4.02 K | 0.00% | 0.00% |
| FMR LLC | 11/13/2025 | 573 | $3.83 K | 84.24% | 0.00% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 487 | $3.26 K | 100.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 11/07/2025 | 384 | $2.57 K | 100.00% | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 11/14/2025 | 368 | $2.46 K | 0.27% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 260 | $1.74 K | -87.55% | 0.00% |
| AMALGAMATED BANK | 10/29/2025 | 201 | $1.00 K | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/10/2025 | 70 | $469 | 100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 11/14/2025 | 60 | $401 | 100.00% | 0.00% |
| STERLING CAPITAL MANAGEMENT LLC | 11/12/2025 | 15 | $100 | 7.14% | 0.00% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | 10/30/2025 | 0 | $0 | -100.00% | 0.00% |
Actuate Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 44 institutional investors and hedge funds held shares of Actuate Therapeutics Inc. The most heavily invested institutionals were:
BIOS Capital Management, LP: 10.05 M
Voss Capital, LLC: 896,278
VANGUARD GROUP INC: 316,010
BlackRock, Inc.: 282,074
GEODE CAPITAL MANAGEMENT, LLC: 145,412
NORTHERN TRUST CORP: 85,454
61.21% of Actuate Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 12.03 M shares in the last 24 months. This purchase volume represents approximately $88.39 M in transactions.